Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Maravai LifeSciences Holdings, Inc. (MRVI)
USD6.36
+0.27 (+4.43%)
US NASDAQ Healthcare Biotechnology
Address
10770 Wateridge Circle 92121
San Diego, CA, US
San Diego, CA, US
CEO
Bernd Brust
Website
maravai.com
IPO
2020-11-20
CIK 1823239 ISIN US56600D1072
Description
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment specializes in manufacturing and distributing products integral to gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics. This encompasses reagents utilized in the chemical synthesis, modification, labeling, and purification of DNA and RNA. Additionally, this division provides messenger RNA, oligonucleotides, their foundational building blocks, plasmid DNA, and the proprietary CleanCap capping technology. Meanwhile, the Biologics Safety Testing segment offers analytical products vital for developing biologic manufacturing processes. Its offerings include bespoke antibody and assay development services tailored to specific products, alongside HCP ELISA kits, various other ELISA kits for identifying bioprocess impurities and contaminants, ancillary reagents, and custom service solutions. Maravai's clientele spans biopharmaceutical companies, other life sciences and biopharmaceutical research firms, academic research institutions, and in vitro diagnostics companies. Incorporated in 2020, Maravai LifeSciences Holdings, Inc. maintains its headquarters in San Diego, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.36
+0.27 (+4.43%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.65
Float Shares
97.45M
Free Float %
67.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.27% | +19.10% | +54.40% | +56.95% | +45.85% | +45.85% | +123.58% | -68.04% | -86.90% | -84.12% | -84.12% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (14 ratings, all time)
Buy
Price Targets & DCF
Current price
6.36
Low
4.50
-29.2%
Consensus
5.25
-17.5%
Median
5.25
-17.5%
High
6.00
-5.7%
DCF (Unlevered)
2.43
-61.7%
DCF (Levered)
2.12
-66.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
56% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 4 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
4.50
-29.2%
|
| All Time | 5 |
13.30
+109.1%
|
Quality scores
Altman Z-Score
2.25
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-28.3% Q1'26: +40.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+13.3% Q1'26: +87.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-102.8% Q1'26: +6.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-112.0% Q1'26: +3.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-108.7% Q1'26: +4.1% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+5.2% Q1'26: +2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.24× Q1'26: 0.57× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 3 EPS Ana. |
Dec 2027 7 Rev. Ana. 5 EPS Ana. |
Dec 2028 4 Rev. Ana. 1 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
284.10M
est: 275.25M (+3.2%)
|
799.24M
est: 779.14M (+2.6%)
|
883.00M
est: 883.43M (0.0%)
|
288.95M
est: 278.59M (+3.7%)
|
259.19M
est: 260.15M (-0.4%)
|
185.74M
est: 184.93M (+0.4%)
|
210.80M
210.38M – 211.12M
+14.0% YoY
|
225.61M
223.50M – 229.00M
+7.0% YoY
|
240.99M
238.77M – 243.21M
+6.8% YoY
|
254.60M
251.04M – 257.95M
+5.6% YoY
|
270.60M
266.82M – 274.16M
+6.3% YoY
|
| EBITDA |
138.27M
est: 126.89M (+9.0%)
|
585.78M
est: 223.17M (+162.5%)
|
609.99M
est: 315.19M (+93.5%)
|
712.41M
est: 57.18M (+1,145.9%)
|
-156.92M
est: 53.40M (-393.9%)
|
-147.11M
est: 37.96M (-487.6%)
|
43.27M
43.18M – 43.33M
+14.0% YoY
|
46.31M
45.88M – 47.00M
+7.0% YoY
|
49.47M
49.01M – 49.92M
+6.8% YoY
|
52.26M
51.53M – 52.95M
+5.6% YoY
|
55.54M
54.77M – 56.27M
+6.3% YoY
|
| EBIT |
112.44M
est: 105.73M (+6.3%)
|
561.03M
est: 408.74M (+37.3%)
|
571.89M
est: 556.88M (+2.7%)
|
663.63M
est: 29.24M (+2,169.6%)
|
-213.78M
est: 27.30M (-883.0%)
|
-207.98M
est: 19.41M (-1,171.5%)
|
22.12M
22.08M – 22.16M
+14.0% YoY
|
23.68M
23.46M – 24.03M
+7.0% YoY
|
25.29M
25.06M – 25.53M
+6.8% YoY
|
26.72M
26.35M – 27.07M
+5.6% YoY
|
28.40M
28.00M – 28.78M
+6.3% YoY
|
| Net Income |
76.89M
est: 49.00M (+56.9%)
|
182.04M
est: 134.92M (+34.9%)
|
220.21M
est: 75.50M (+191.7%)
|
-119.03M
est: -143.93M (+17.3%)
|
-144.85M
est: -12.18M (-1,088.7%)
|
-130.77M
est: -46.08M (-183.8%)
|
-19.30M
-24.74M – -13.86M
+58.1% YoY
|
-15.76M
-21.30M – -10.23M
+18.3% YoY
|
-11.86M
-12.07M – -11.65M
+24.8% YoY
|
-21.76M
-22.13M – -21.37M
-83.5% YoY
|
-20.31M
-20.66M – -19.94M
+6.7% YoY
|
| SGA |
94.25M
est: 96.42M (-2.3%)
|
100.06M
est: 72.67M (+37.7%)
|
129.26M
est: 94.73M (+36.5%)
|
151.39M
est: 130.54M (+16.0%)
|
161.77M
est: 121.90M (+32.7%)
|
171.47M
est: 86.65M (+97.9%)
|
98.77M
98.58M – 98.92M
+14.0% YoY
|
105.71M
104.73M – 107.30M
+7.0% YoY
|
112.92M
111.88M – 113.96M
+6.8% YoY
|
119.30M
117.63M – 120.87M
+5.6% YoY
|
126.79M
125.02M – 128.46M
+6.3% YoY
|
| EPS |
7.43
est: 0.36 (+1,991.0%)
|
1.59
est: 1.52 (+4.8%)
|
1.67
est: 1.79 (-6.9%)
|
-0.90
est: -0.99 (+9.3%)
|
-1.05
est: -0.08 (-1,239.4%)
|
-0.91
est: -0.31 (-191.3%)
|
-0.12
-0.17 – -0.10
+60.7% YoY
|
-0.10
-0.15 – -0.07
+18.7% YoY
|
-0.08
-0.08 – -0.08
+18.1% YoY
|
-0.15
-0.15 – -0.15
-83.4% YoY
|
-0.14
-0.14 – -0.14
+6.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-92.64M
OE per share TTM
-0.64
Owner's Yield
-8.43%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
29.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
28
Total invested
7.70M
Insider transactions (90d)
0
Beneficial owners (>5%)
25
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GTCR Investment XI LLC | 188.62M | 73.20% | — | 188.62M | — | 188.62M | OO | Delaware | 2021-02-11 | ↗ |
| 2 | GTCR Co-Invest XI LP | 160.97M | 62.50% | — | 160.97M | — | 160.97M | PN | Delaware | 2021-02-11 | ↗ |
| 3 | GTCR Fund XI/B LP | 160.97M | 62.50% | — | 160.97M | — | 160.97M | PN | Delaware | 2021-02-11 | ↗ |
| 4 | GTCR Partners XI/B LP | 160.97M | 62.50% | — | 160.97M | — | 160.97M | PN | Delaware | 2021-02-11 | ↗ |
| 5 | Maravai Life Sciences Holdings, LLC | 160.97M | 4.00% | — | 160.97M | — | 160.97M | OO | Delaware | 2021-02-11 | ↗ |
| 6 | GTCR Fund XI/C LP | 27.65M | 28.60% | — | 27.65M | — | 27.65M | PN | Delaware | 2021-02-11 | ↗ |
| 7 | GTCR Partners XI/A&C LP | 27.65M | 28.60% | — | 27.65M | — | 27.65M | PN | Delaware | 2021-02-11 | ↗ |
| 8 | Maravai Life Sciences Holdings 2, LLC | 27.65M | 28.60% | — | 27.65M | — | 27.65M | OO | Delaware | 2021-02-11 | ↗ |
| 9 | George S. Loening | 14.93M | 11.40% | — | 14.93M | — | — | HC, IN | Delaware | 2021-11-09 | ↗ |
| 10 | Select Equity Group, L.P. | 14.93M | 11.40% | — | 14.93M | — | — | IA | Delaware | 2021-11-09 | ↗ |
| 11 | 04-2747644 | 13.93M | 10.60% | 13.03M | — | 13.93M | — | IA | Delaware | 2022-09-06 | ↗ |
| 12 | The Vanguard Group - 23-1945930 | 10.53M | 8.01% | — | 65.8K | 10.37M | 164.8K | IA | Pennsylvania | 2022-02-10 | ↗ |
| 13 | (1) BlackRock, Inc. | 10.48M | 7.40% | 10.25M | — | 10.48M | — | HC | Delaware | 2024-11-08 | ↗ |
| 14 | Israel A. Englander | 7.13M | 5.40% | — | 7.13M | — | 7.13M | IN | Delaware | 2024-05-14 | ↗ |
| 15 | Millennium Group Management LLC | 7.13M | 5.40% | — | 7.13M | — | 7.13M | OO | Delaware | 2024-05-14 | ↗ |
| 16 | Millennium Management LLC | 7.13M | 5.40% | — | 7.13M | — | 7.13M | OO | Delaware | 2024-05-14 | ↗ |
| 17 | Steven A. Cohen | 6.65M | 5.00% | — | 6.65M | — | — | IN | Delaware | 2024-06-10 | ↗ |
| 18 | D1 Capital Partners L.P. | 5.93M | 6.10% | — | 5.93M | — | 5.93M | IA, PN | Delaware | 2021-02-16 | ↗ |
| 19 | Daniel Sundheim | 5.93M | 6.10% | — | 5.93M | — | 5.93M | HC, IN | United States of America | 2021-02-16 | ↗ |
| 20 | Abigail P. Johnson | 5.71M | 6.41% | — | — | 5.71M | — | IN | United States of America | 2021-02-08 | ↗ |
| 21 | FMR LLC | 5.71M | 6.41% | 512.0K | — | 5.71M | — | HC | Delaware | 2021-02-08 | ↗ |
| 22 | Point72 Asset Management, L.P. | 4.48M | 3.40% | — | 4.48M | — | — | PN | Delaware | 2024-06-10 | ↗ |
| 23 | Point72 Capital Advisors, Inc. | 4.48M | 3.40% | — | 4.48M | — | — | CO | Delaware | 2024-06-10 | ↗ |
| 24 | Point72 Europe (London) LLP | 2.17M | 1.60% | — | 2.17M | — | — | OO | Delaware | 2024-06-10 | ↗ |
| 25 | Advent Venture Partners LLP, Advent Private Equity Fund III Affiliates, Advent Management III Limite | 1.12M | 4.30% | 11.60M | — | 11.60M | — | PN | Delaware, United States | 2024-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
28
-138 vs prev Q
New positions
5
Closed positions
139
Increased
14
Reduced
6
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GTCR LLC | 20.15M +— (+0.0%) | 65.49M +7.7M (+13.2%) | 13.93% -0.043 pp | 10.88% +4.494 pp | USD28.05 -88.4% | 21 qtrs — |
| 2 | BLACKROCK, INC. | 9.38M +274.6K (+3.0%) | 30.48M +4.4M (+16.7%) | 6.48% +0.170 pp | 0.00% +0.000 pp | USD8.08 -59.8% | 6 qtrs — |
| 3 | 12 WEST CAPITAL MANAGEMENT LP | 8.92M -3.6M (-28.8%) | 28.99M -6.9M (-19.3%) | 6.17% -2.515 pp | 3.45% -0.274 pp | USD8.82 -63.2% | 12 qtrs — |
| 4 | BRAIDWELL LP | 8.35M +— (+0.0%) | 27.15M +3.2M (+13.2%) | 5.77% -0.018 pp | 0.87% +0.157 pp | USD9.13 -64.4% | 11 qtrs — |
| 5 | VANGUARD GROUP INC | 7.17M +41.0K (+0.6%) | 23.29M +2.8M (+13.9%) | 4.95% +0.013 pp | 0.00% +0.000 pp | USD31.16 -89.6% | 21 qtrs — |
| 6 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.34M +178.4K (+2.9%) | 20.60M +2.9M (+16.5%) | 4.38% +0.110 pp | 0.01% +0.002 pp | USD2.69 +20.8% | 3 qtrs — |
| 7 | MACKENZIE FINANCIAL CORP | 6.17M +104.4K (+1.7%) | 20.15M +2.7M (+15.7%) | 4.27% +0.059 pp | 0.02% +0.003 pp | USD11.31 -71.3% | 14 qtrs — |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 4.23M -93.0K (-2.2%) | 13.73M +1.3M (+10.8%) | 2.92% -0.074 pp | 0.02% +0.005 pp | USD15.88 -79.5% | 19 qtrs — |
| 9 | MONACO ASSET MANAGEMENT SAM | 3.46M -196.1K (-5.4%) | 11.25M +751.9K (+7.2%) | 2.39% -0.143 pp | 1.95% +1.310 pp | USD3.00 +8.3% | 9 qtrs — |
| 10 | MORGAN STANLEY | 3.45M +563.0K (+19.5%) | 11.20M +2.9M (+35.3%) | 2.38% +0.383 pp | 0.00% +0.000 pp | USD9.87 -67.1% | 21 qtrs — |
| 11 | PHILOSOPHY CAPITAL MANAGEMENT LLC | 3.10M +507.1K (+19.6%) | 10.08M +2.6M (+35.4%) | 2.14% +0.345 pp | 0.46% +0.154 pp | USD2.38 +36.6% | 4 qtrs — |
| 12 | TEJARA CAPITAL LTD | 3.02M +566.8K (+23.1%) | 9.82M +2.8M (+39.4%) | 2.09% +0.387 pp | 2.31% -1.363 pp | USD2.61 +24.5% | 4 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 2.85M +34.4K (+1.2%) | 9.26M +1.2M (+14.6%) | 1.97% +0.018 pp | 0.00% +0.000 pp | USD22.33 -85.4% | 21 qtrs — |
| 14 | POINT72 ASSET MANAGEMENT, L.P. | 2.85M +2.8M (+8,597.7%) | 9.26M +9.2M (+9,749.2%) | 1.97% +1.946 pp | 0.01% +0.010 pp | USD3.25 +0.0% | 2 qtrs — |
| 15 | STATE STREET CORP | 2.41M +27.2K (+1.1%) | 7.85M +995.5K (+14.5%) | 1.67% +0.014 pp | 0.00% +0.000 pp | USD26.85 -87.9% | 20 qtrs — |
| 16 | WELLINGTON MANAGEMENT GROUP LLP | 2.36M +2.4M (+100.0%) | 7.67M +7.7M (+100.0%) | 1.63% +1.631 pp | 0.00% +0.001 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 17 | MIRABELLA FINANCIAL SERVICES LLP | 2.11M -1.6M (-43.7%) | 6.86M -3.9M (-36.3%) | 1.46% -1.141 pp | 0.64% -0.273 pp | USD2.21 +47.1% | 4 qtrs — |
| 18 | GOLDMAN SACHS GROUP INC | 2.01M +442.1K (+28.1%) | 6.55M +2.0M (+45.1%) | 1.39% +0.302 pp | 0.00% +0.000 pp | USD7.20 -54.9% | 21 qtrs — |
| 19 | MARSHALL WACE, LLP | 2.00M +687.3K (+52.3%) | 6.50M +2.7M (+72.5%) | 1.38% +0.472 pp | 0.01% +0.002 pp | USD3.42 -5.0% | 21 qtrs — |
| 20 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 1.80M +1.3M (+299.0%) | 5.85M +4.6M (+351.9%) | 1.24% +0.931 pp | 0.01% +0.008 pp | USD3.15 +3.2% | 2 qtrs — |
| 21 | MILLENNIUM MANAGEMENT LLC | 1.80M +1.4M (+308.7%) | 5.84M +4.6M (+362.8%) | 1.24% +0.937 pp | 0.00% +0.002 pp | USD3.99 -18.5% | 21 qtrs — |
| 22 | ROYCE & ASSOCIATES LP | 1.71M -55.6K (-3.2%) | 5.54M +488.7K (+9.7%) | 1.18% -0.042 pp | 0.06% +0.006 pp | USD5.22 -37.7% | 8 qtrs — |
| 23 | GENERAL AMERICAN INVESTORS CO INC | 1.59M +1.4M (+1,062.2%) | 5.15M +4.8M (+1,216.1%) | 1.10% +1.001 pp | 0.29% +0.268 pp | USD3.22 +0.9% | 2 qtrs — |
| 24 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 1.52M -2.5K (-0.2%) | 4.94M +570.6K (+13.1%) | 1.05% -0.005 pp | 0.12% +0.010 pp | USD10.86 -70.1% | 13 qtrs — |
| 25 | JANE STREET GROUP, LLC | 1.30M +741.5K (+134.0%) | 4.21M +2.6M (+164.9%) | 0.90% +0.511 pp | 0.00% +0.000 pp | USD3.07 +5.9% | 21 qtrs — |
| 26 | LAZARD ASSET MANAGEMENT LLC | 1.02M -521.5K (-33.9%) | 3.31M -1.1M (-25.1%) | 0.70% -0.364 pp | 0.01% 0.000 pp | USD6.99 -53.5% | 21 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 988.0K -649.0 (-0.1%) | 3.21M +373.6K (+13.2%) | 0.68% -0.003 pp | 0.00% +0.000 pp | USD23.08 -85.9% | 20 qtrs — |
| 28 | FIRST PACIFIC ADVISORS, LP | 884.9K +— (+0.0%) | 2.88M +336.3K (+13.2%) | 0.61% -0.002 pp | 0.04% +0.003 pp | USD2.48 +31.0% | 3 qtrs — |
| 29 | NORTHERN TRUST CORP | 880.9K -45.8K (-4.9%) | 2.86M +203.2K (+7.6%) | 0.61% -0.034 pp | 0.00% +0.000 pp | USD18.68 -82.6% | 20 qtrs — |
| 30 | TWO SIGMA ADVISERS, LP | 876.7K -774.7K (-46.9%) | 2.85M -1.9M (-39.9%) | 0.61% -0.539 pp | 0.01% -0.004 pp | USD3.58 -9.2% | 21 qtrs — |
| 31 | DIMENSIONAL FUND ADVISORS LP | 860.5K -76.0K (-8.1%) | 2.80M +109.3K (+4.1%) | 0.59% -0.055 pp | 0.00% +0.000 pp | USD12.53 -74.1% | 18 qtrs — |
| 32 | DEUTSCHE BANK AG\ | 847.5K -1.0M (-55.1%) | 2.75M -2.7M (-49.2%) | 0.59% -0.723 pp | 0.00% -0.001 pp | USD5.00 -35.0% | 21 qtrs — |
| 33 | TWO SIGMA INVESTMENTS, LP | 845.4K -326.8K (-27.9%) | 2.75M -616.8K (-18.3%) | 0.58% -0.228 pp | 0.00% -0.001 pp | USD2.93 +10.9% | 21 qtrs — |
| 34 | UBS GROUP AG | 738.9K -1.7M (-69.2%) | 2.40M -4.5M (-65.1%) | 0.51% -1.153 pp | 0.00% -0.001 pp | USD3.03 +7.3% | 21 qtrs — |
| 35 | EVERSEPT PARTNERS, LP | 718.6K +427.9K (+147.2%) | 2.34M +1.5M (+179.9%) | 0.50% +0.295 pp | 0.12% +0.060 pp | USD2.83 +14.8% | 6 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 701.7K -730.7K (-51.0%) | 2.28M -1.8M (-44.5%) | 0.49% -0.508 pp | 0.00% 0.000 pp | USD6.83 -52.4% | 21 qtrs — |
| 37 | CITADEL ADVISORS LLC | 617.5K +528.6K (+594.9%) | 2.01M +1.8M (+686.9%) | 0.43% +0.365 pp | 0.00% +0.000 pp | USD3.11 +4.5% | 21 qtrs — |
| 38 | CITIGROUP INC | 522.0K +199.7K (+61.9%) | 1.70M +771.4K (+83.4%) | 0.36% +0.137 pp | 0.00% +0.000 pp | USD4.61 -29.5% | 21 qtrs — |
| 39 | CERITY PARTNERS LLC | 467.9K +467.9K (+100.0%) | 1.52M +1.5M (+100.0%) | 0.32% +0.323 pp | 0.00% +0.002 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 40 | BRUMMER MULTI-STRATEGY AB | 457.7K +457.7K (+100.0%) | 1.49M +1.5M (+100.0%) | 0.32% +0.316 pp | 8.99% +8.992 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 41 | SG AMERICAS SECURITIES, LLC | 427.3K -73.0K (-14.6%) | 1.39M -47.0K (-3.3%) | 0.30% -0.052 pp | 0.00% -0.003 pp | USD2.49 +30.5% | 9 qtrs — |
| 42 | JPMORGAN CHASE & CO | 424.3K +154.5K (+57.3%) | 1.38M +604.7K (+78.1%) | 0.29% +0.106 pp | 0.00% +0.000 pp | USD7.02 -53.7% | 21 qtrs — |
| 43 | DELTA INVESTMENT MANAGEMENT, LLC | 415.6K -54.5K (-11.6%) | 1.35M +1.4K (+0.1%) | 0.29% -0.039 pp | 0.23% -0.007 pp | USD4.84 -32.9% | 6 qtrs — |
| 44 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 410.7K +67.0K (+19.5%) | 1.33M +348.4K (+35.3%) | 0.28% +0.046 pp | 0.00% +0.000 pp | USD4.97 -34.6% | 21 qtrs — |
| 45 | HRT FINANCIAL LP | 367.9K +367.9K (+100.0%) | 1.20M +1.2M (+100.0%) | 0.25% +0.254 pp | 0.00% +0.004 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 46 | INVESCO LTD. | 345.8K +38.0K (+12.3%) | 1.12M +240.3K (+27.2%) | 0.24% +0.026 pp | 0.00% +0.000 pp | USD9.47 -65.7% | 21 qtrs — |
| 47 | BANK OF NEW YORK MELLON CORP | 334.7K -3.2K (-1.0%) | 1.09M +118.0K (+12.2%) | 0.23% -0.003 pp | 0.00% +0.000 pp | USD24.32 -86.6% | 20 qtrs — |
| 48 | CIBC PRIVATE WEALTH GROUP, LLC | 279.2K -132.3K (-32.1%) | 907.5K -273.5K (-23.2%) | 0.19% -0.092 pp | 0.00% -0.001 pp | USD2.22 +46.4% | 6 qtrs — |
| 49 | QUINN OPPORTUNITY PARTNERS LLC | 265.1K +— (+0.0%) | 861.5K +100.7K (+13.2%) | 0.18% -0.001 pp | 0.04% -0.018 pp | USD3.30 -1.5% | 11 qtrs — |
| 50 | SYMMETRY INVESTMENTS LP | 259.0K -26.0K (-9.1%) | 841.9K +23.9K (+2.9%) | 0.18% -0.019 pp | 0.07% +0.034 pp | USD3.28 -0.9% | 7 qtrs — |
| 51 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 236.3K +208.5K (+748.3%) | 768.0K +688.1K (+860.6%) | 0.16% +0.144 pp | 0.01% +0.011 pp | USD3.21 +1.2% | 2 qtrs — |
| 52 | NUVEEN, LLC | 228.7K -12.5K (-5.2%) | 743.3K +51.1K (+7.4%) | 0.16% -0.009 pp | 0.00% +0.000 pp | USD2.21 +47.1% | 4 qtrs — |
| 53 | CREATIVE PLANNING | 224.4K +30.6K (+15.8%) | 729.2K +173.2K (+31.2%) | 0.16% +0.021 pp | 0.00% +0.000 pp | USD4.76 -31.7% | 16 qtrs — |
| 54 | PENDERFUND CAPITAL MANAGEMENT LTD. | 220.5K -199.4K (-47.5%) | 716.6K -488.4K (-40.5%) | 0.15% -0.139 pp | 0.11% -0.090 pp | USD4.38 -25.8% | 5 qtrs — |
| 55 | MASSAR CAPITAL MANAGEMENT, LP | 200.0K +— (+0.0%) | 650.0K +76.0K (+13.2%) | 0.14% 0.000 pp | 0.07% -0.006 pp | USD2.21 +47.1% | 4 qtrs — |
| 56 | BARCLAYS PLC | 172.3K -11.9K (-6.5%) | 559.9K -970.7K (-63.4%) | 0.12% -0.009 pp | 0.00% 0.000 pp | USD7.03 -53.8% | 16 qtrs — |
| 57 | ALLIANCEBERNSTEIN L.P. | 170.6K -17.7K (-9.4%) | 554.5K +14.0K (+2.6%) | 0.12% -0.013 pp | 0.00% +0.000 pp | USD10.54 -69.2% | 20 qtrs — |
| 58 | STRS OHIO | 164.3K -44.5K (-21.3%) | 534.0K -65.3K (-10.9%) | 0.11% -0.031 pp | 0.00% 0.000 pp | USD4.50 -27.8% | 7 qtrs — |
| 59 | JACOBS LEVY EQUITY MANAGEMENT, INC | 161.1K -37.8K (-19.0%) | 523.5K -47.3K (-8.3%) | 0.11% -0.027 pp | 0.00% 0.000 pp | USD2.81 +15.7% | 5 qtrs — |
| 60 | CAXTON ASSOCIATES LLP | 150.8K +150.8K (+100.0%) | 489.9K +489.9K (+100.0%) | 0.10% +0.104 pp | 0.01% +0.010 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 61 | RHUMBLINE ADVISERS | 150.6K -24.0K (-13.8%) | 489.3K -11.7K (-2.3%) | 0.10% -0.017 pp | 0.00% +0.000 pp | USD18.56 -82.5% | 20 qtrs — |
| 62 | TD ASSET MANAGEMENT INC | 146.0K +— (+0.0%) | 474.4K +55.5K (+13.2%) | 0.10% 0.000 pp | 0.00% +0.000 pp | USD2.67 +21.7% | 3 qtrs — |
| 63 | RUSSELL INVESTMENTS GROUP, LTD. | 132.7K +20.4K (+18.2%) | 431.4K +109.1K (+33.8%) | 0.09% +0.014 pp | 0.00% +0.000 pp | USD2.73 +19.0% | 4 qtrs — |
| 64 | DEKABANK DEUTSCHE GIROZENTRALE | 44.0K +— (+0.0%) | 411.0K +288.0K (+234.1%) | 0.03% 0.000 pp | 0.00% +0.001 pp | USD41.90 -92.2% | 19 qtrs — |
| 65 | YOST CAPITAL MANAGEMENT, LP | 126.1K +126.1K (+100.0%) | 409.7K +409.7K (+100.0%) | 0.09% +0.087 pp | 0.59% +0.595 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 66 | WELLS FARGO & COMPANY/MN | 123.0K +38.7K (+46.0%) | 399.9K +157.9K (+65.3%) | 0.09% +0.027 pp | 0.00% +0.000 pp | USD6.58 -50.6% | 21 qtrs — |
| 67 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 117.2K -10.9K (-8.5%) | 381.0K +13.1K (+3.6%) | 0.08% -0.008 pp | 0.00% +0.000 pp | USD6.15 -47.2% | 6 qtrs — |
| 68 | PRICE T ROWE ASSOCIATES INC /MD/ | 116.0K +— (+0.0%) | 377.0K +44.0K (+13.2%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD23.37 -86.1% | 20 qtrs — |
| 69 | BNP PARIBAS ARBITRAGE, SNC | 112.6K +79.3K (+237.7%) | 366.0K +270.3K (+282.4%) | 0.08% +0.055 pp | 0.00% +0.000 pp | USD3.41 -4.7% | 5 qtrs — |
| 70 | AQR CAPITAL MANAGEMENT LLC | 111.1K +49.6K (+80.5%) | 361.2K +184.4K (+104.4%) | 0.08% +0.034 pp | 0.00% +0.000 pp | USD4.11 -20.9% | 17 qtrs — |
| 71 | EPACRIA CAPITAL PARTNERS, LLC | 100.1K +— (+0.0%) | 325.3K +38.0K (+13.2%) | 0.07% 0.000 pp | 0.26% +0.025 pp | USD2.33 +39.5% | 4 qtrs — |
| 72 | ALPINE PEAKS CAPITAL, LP | 96.9K -47.6K (-32.9%) | 314.9K -99.8K (-24.1%) | 0.07% -0.033 pp | 0.30% -0.060 pp | USD2.87 +13.2% | 2 qtrs — |
| 73 | EMPOWERED FUNDS, LLC | 95.3K +2.0K (+2.2%) | 309.8K +42.0K (+15.7%) | 0.07% +0.001 pp | 0.00% 0.000 pp | USD3.34 -2.7% | 5 qtrs — |
| 74 | IRENIC CAPITAL MANAGEMENT LP | 80.7K +60.0K (+290.3%) | 262.2K +202.9K (+342.0%) | 0.06% +0.041 pp | 0.02% +0.011 pp | USD3.03 +7.3% | 3 qtrs — |
| 75 | SUMMIT TRAIL ADVISORS, LLC | 80.4K -4.9K (-5.8%) | 261.5K +16.4K (+6.7%) | 0.06% -0.004 pp | 0.00% +0.001 pp | USD2.41 +34.9% | 3 qtrs — |
| 76 | XTX TOPCO LTD | 76.7K -35.8K (-31.8%) | 249.3K -73.5K (-22.8%) | 0.05% -0.025 pp | 0.01% -0.010 pp | USD2.87 +13.2% | 10 qtrs — |
| 77 | FRANKLIN RESOURCES INC | 75.7K -27.2K (-26.5%) | 246.0K -49.4K (-16.7%) | 0.05% -0.019 pp | 0.00% +0.000 pp | USD3.59 -9.5% | 6 qtrs — |
| 78 | ALPHA WEALTH FUNDS, LLC | 72.0K +— (+0.0%) | 244.8K +69.1K (+39.3%) | 0.05% 0.000 pp | 0.15% +0.023 pp | USD5.36 -39.4% | 5 qtrs — |
| 79 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 66.5K +66.5K (+100.0%) | 226.0K +226.0K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.000 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 80 | QUANTBOT TECHNOLOGIES LP | 60.3K +29.4K (+95.4%) | 196.1K +107.4K (+121.3%) | 0.04% +0.020 pp | 0.01% +0.004 pp | USD3.06 +6.2% | 2 qtrs — |
| 81 | BANK OF MONTREAL /CAN/ | 59.5K +— (+0.0%) | 193.2K +22.6K (+13.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD2.64 +23.1% | 9 qtrs — |
| 82 | INTECH INVESTMENT MANAGEMENT LLC | 54.2K -7.2K (-11.8%) | 176.2K -121.0 (-0.1%) | 0.04% -0.005 pp | 0.00% +0.000 pp | USD4.89 -33.5% | 6 qtrs — |
| 83 | AXQ CAPITAL, LP | 44.0K +17.1K (+63.8%) | 143.0K +65.9K (+85.5%) | 0.03% +0.012 pp | 0.03% +0.003 pp | USD3.02 +7.6% | 4 qtrs — |
| 84 | METLIFE INVESTMENT MANAGEMENT, LLC | 43.3K -15.4K (-26.2%) | 140.9K -27.6K (-16.4%) | 0.03% -0.011 pp | 0.00% 0.000 pp | USD6.55 -50.4% | 16 qtrs — |
| 85 | AQUATIC CAPITAL MANAGEMENT LLC | 41.5K +41.5K (+100.0%) | 134.7K +134.7K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.004 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 86 | SKOPOS LABS, INC. | 40.4K -95.9K (-70.3%) | 134.7K -202.1K (-60.0%) | 0.03% -0.067 pp | 0.01% -0.030 pp | USD2.41 +34.9% | 3 qtrs — |
| 87 | STATE OF WISCONSIN INVESTMENT BOARD | 40.9K +40.9K (+100.0%) | 132.9K +132.9K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 88 | FMR LLC | 35.3K +1.9K (+5.8%) | 114.8K +19.0K (+19.8%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD5.94 -45.3% | 21 qtrs — |
| 89 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 34.5K -8.5K (-19.9%) | 112.0K -11.4K (-9.3%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD6.76 -51.9% | 10 qtrs — |
| 90 | NEW YORK STATE COMMON RETIREMENT FUND | 32.7K +— (+0.0%) | 106.4K +12.4K (+13.2%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD21.08 -84.6% | 20 qtrs — |
| 91 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 31.6K +— (+0.0%) | 102.8K +12.0K (+13.2%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD40.67 -92.0% | 19 qtrs — |
| 92 | QUENT CAPITAL, LLC | 30.0K +30.0K (+74,900.0%) | 97.5K +97.4K (+84,682.6%) | 0.02% +0.021 pp | 0.01% +0.007 pp | USD3.25 +0.0% | 17 qtrs — |
| 93 | PROSHARE ADVISORS LLC | 26.4K +2.5K (+10.6%) | 85.7K +17.3K (+25.3%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD6.60 -50.8% | 6 qtrs — |
| 94 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 23.7K -10.8K (-31.3%) | 77.0K -22.1K (-22.3%) | 0.02% -0.008 pp | 0.00% 0.000 pp | USD4.52 -28.1% | 5 qtrs — |
| 95 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 23.6K -1.7K (-6.8%) | 76.8K +4.0K (+5.5%) | 0.02% -0.001 pp | 0.01% 0.000 pp | USD8.12 -60.0% | 14 qtrs — |
| 96 | TWO SIGMA SECURITIES, LLC | 21.6K +21.6K (+100.0%) | 70.2K +70.2K (+100.0%) | 0.01% +0.015 pp | 0.01% +0.010 pp | USD3.25 +0.0% | 1 qtrs NEW |
| 97 | VOYA INVESTMENT MANAGEMENT LLC | 20.9K +— (+0.0%) | 68.0K +8.0K (+13.2%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD7.10 -54.2% | 20 qtrs — |
| 98 | HEADLANDS TECHNOLOGIES LLC | 20.3K +20.3K (+100.0%) | 65.9K +65.9K (+100.0%) | 0.01% +0.014 pp | 0.01% +0.006 pp | USD3.25 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
129.5K
Cash buys
—
Cash sales
—
Net activity
-129,473
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 39,976 | 3.08 | 123.1K | 384,991 | D | ↗ |
| 2026-03-16 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 28,661 | 3.08 | 88.3K | 420,312 | D | ↗ |
| 2026-01-15 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 31,902 | 3.69 | 117.7K | 424,967 | D | ↗ |
| 2026-01-15 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 28,934 | 3.69 | 106.8K | 448,973 | D | ↗ |
| 2025-12-08 | LUCIER GREGORY T | Director | P-Purchase | A | Class A Common Stock | 48,528 | 3.67 | 178.1K | 155,123 | D | ↗ |
| 2025-12-05 | LUCIER GREGORY T | Director | P-Purchase | A | Class A Common Stock | 51,472 | 3.70 | 190.4K | 106,595 | D | ↗ |
| 2025-11-14 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 4,300 | 1.79 | 7.7K | 477,907 | D | ↗ |
| 2025-11-13 | Brust Bernd | Director / Officer | P-Purchase | A | Class A Common Stock | 216,212 | 3.25 | 702.7K | 466,771 | I | ↗ |
| 2025-11-12 | Brust Bernd | Director / Officer | P-Purchase | A | Class A Common Stock | 93,358 | 3.21 | 299.7K | 250,559 | I | ↗ |
| 2025-11-11 | Brust Bernd | Director / Officer | P-Purchase | A | Class A Common Stock | 157,201 | 3.24 | 509.3K | 157,201 | I | ↗ |
| 2025-07-15 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 5,154 | 2.59 | 13.3K | 727,177 | D | ↗ |
| 2025-07-10 | LUCIER GREGORY T | Director | G-Gift | A | Class A Common Stock | 89,139 | 0.00 | — | 109,784 | I | ↗ |
| 2025-06-30 | Asarpota Rajesh | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 333,333 | 2.41 | 803.3K | 333,333 | D | ↗ |
| 2025-06-16 | PRAHALAD MURALI | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 154,607 | D | ↗ |
| 2025-06-16 | MIHAS CONSTANTINE S | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 138,055 | D | ↗ |
| 2025-06-16 | MARKER LUKE JOSEPH | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 138,055 | D | ↗ |
| 2025-06-16 | LUCIER GREGORY T | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 144,262 | D | ↗ |
| 2025-06-16 | Hopfield Jessica | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 199,907 | D | ↗ |
| 2025-06-16 | GRAY SUSANNAH | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 169,907 | D | ↗ |
| 2025-06-16 | ECKERT R ANDREW | Director | A-Award | A | Class A Common Stock | 231,481 | 2.16 | 500.0K | 365,890 | D | ↗ |
| 2025-06-16 | DeFord John A | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 159,185 | D | ↗ |
| 2025-06-16 | DAVERMAN BENJAMIN JAMES | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 138,055 | D | ↗ |
| 2025-06-16 | CUNNINGHAM SEAN LAURENCE | Director | A-Award | A | Class A Common Stock | 89,139 | 2.16 | 192.5K | 138,055 | D | ↗ |
| 2025-06-08 | Brust Bernd | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,000,000 | 2.39 | 2.39M | 1,000,000 | D | ↗ |
| 2025-05-15 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 876 | 1.67 | 1.5K | 674,636 | D | ↗ |
| 2025-05-15 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 2,381 | 1.67 | 4.0K | 473,607 | D | ↗ |
| 2025-03-17 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 4,579 | 2.64 | 12.1K | 161,011 | D | ↗ |
| 2025-03-17 | MARTIN WILLIAM E. III | Officer | A-Award | A | Class A Common Stock | 986,194 | 0.00 | — | 1,814,643 | D | ↗ |
| 2025-03-17 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 5,886 | 2.64 | 15.5K | 337,853 | D | ↗ |
| 2025-03-17 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 8,648 | 2.64 | 22.8K | 279,282 | D | ↗ |
| 2025-03-17 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 246,549 | 0.00 | — | 471,226 | D | ↗ |
| 2025-03-17 | BUZZEO REBECCA | Officer | F-InKind | D | Class A Common Stock | 4,314 | 2.64 | 11.4K | 310,933 | D | ↗ |
| 2025-02-18 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 2,028 | 4.10 | 8.3K | 165,590 | D | ↗ |
| 2025-02-18 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 2,326 | 4.10 | 9.5K | 287,930 | D | ↗ |
| 2025-02-18 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 1,621 | 4.10 | 6.6K | 230,013 | D | ↗ |
| 2025-01-31 | ORESHACK KURT | Officer | S-Sale | D | Class A Common Stock | 25,000 | 5.03 | 125.8K | 167,618 | D | ↗ |
| 2025-01-15 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 31,438 | 4.56 | 143.4K | 192,618 | D | ↗ |
| 2025-01-15 | MARTIN WILLIAM E. III | Officer | F-InKind | D | Class A Common Stock | 160,981 | 4.56 | 734.1K | 828,449 | D | ↗ |
| 2025-01-15 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 32,042 | 4.56 | 146.1K | 343,739 | D | ↗ |
| 2025-01-15 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 46,344 | 4.56 | 211.3K | 290,256 | D | ↗ |
| 2025-01-15 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 28,704 | 4.56 | 130.9K | 231,634 | D | ↗ |
| 2025-01-15 | BUZZEO REBECCA | Officer | F-InKind | D | Class A Common Stock | 45,456 | 4.56 | 207.3K | 315,247 | D | ↗ |
| 2025-01-15 | BURCH ANDREW | Officer | F-InKind | D | Class A Common Stock | 54,412 | 4.56 | 248.1K | 369,183 | D | ↗ |
| 2024-12-16 | ECKERT R ANDREW | Director | A-Award | A | Class A Common Stock | 134,409 | 0.00 | — | 134,409 | D | ↗ |
| 2024-12-09 | LUCIER GREGORY T | Director | G-Gift | D | Class A Common Stock | 20,645 | 0.00 | — | 55,123 | D | ↗ |
| 2024-12-05 | ECKERT R ANDREW | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-15 | BUZZEO REBECCA | Officer | F-InKind | D | Class A Common Stock | 4,363 | 4.42 | 19.3K | 360,703 | D | ↗ |
| 2024-11-12 | DeFord John A | Director | P-Purchase | A | Class A Common Stock | 17,500 | 5.75 | 100.6K | 70,046 | D | ↗ |
| 2024-11-11 | HULL CARL | Director / Officer | P-Purchase | A | Class A Common Stock | 175,000 | 5.64 | 987.0K | 175,000 | I | ↗ |
| 2024-10-31 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 366 | 5.70 | 2.1K | 224,056 | D | ↗ |
| 2024-10-31 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 1,906 | 5.70 | 10.9K | 336,600 | D | ↗ |
| 2024-10-31 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 1,848 | 5.70 | 10.5K | 260,338 | D | ↗ |
| 2024-10-31 | BURCH ANDREW | Officer | A-Award | A | Class A Common Stock | 1,841 | 5.70 | 10.5K | 423,595 | D | ↗ |
| 2024-10-15 | MARTIN WILLIAM E. III | Officer | F-InKind | D | Class A Common Stock | 50,843 | 8.29 | 421.5K | 989,430 | D | ↗ |
| 2024-07-15 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 5,154 | 8.76 | 45.1K | 375,781 | — | ↗ |
| 2024-05-28 | GTCR INVESTMENT XI LLC | Director / 10% Owner | C-Conversion | D | Common Units | 8,409,946 | 0.00 | — | 110,684,080 | — | ↗ |
| 2024-05-23 | PRAHALAD MURALI | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 65,468 | — | ↗ |
| 2024-05-23 | MIHAS CONSTANTINE S | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 48,916 | — | ↗ |
| 2024-05-23 | MARKER LUKE JOSEPH | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 48,916 | — | ↗ |
| 2024-05-23 | LUCIER GREGORY T | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 75,768 | — | ↗ |
| 2024-05-23 | Hopfield Jessica | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 110,768 | — | ↗ |
| 2024-05-23 | GRAY SUSANNAH | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 80,768 | — | ↗ |
| 2024-05-23 | DeFord John A | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 52,546 | — | ↗ |
| 2024-05-23 | DAVERMAN BENJAMIN JAMES | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 48,916 | — | ↗ |
| 2024-05-23 | CUNNINGHAM SEAN LAURENCE | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 48,916 | — | ↗ |
| 2024-05-23 | Ashkenazi Anat | Director | A-Award | A | Class A Common Stock | 20,645 | 10.78 | 222.6K | 60,768 | — | ↗ |
| 2024-04-30 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 341 | 5.70 | 1.9K | 223,690 | — | ↗ |
| 2024-04-30 | Leddy Peter Michael | Officer | A-Award | A | Class A Common Stock | 4,576 | 5.70 | 26.1K | 380,935 | — | ↗ |
| 2024-04-30 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 1,780 | 5.70 | 10.1K | 334,694 | — | ↗ |
| 2024-04-30 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 483 | 5.70 | 2.8K | 258,490 | — | ↗ |
| 2024-04-30 | BURCH ANDREW | Officer | A-Award | A | Class A Common Stock | 1,719 | 5.70 | 9.8K | 421,754 | — | ↗ |
| 2024-04-15 | BURCH ANDREW | Officer | F-InKind | D | Class A Common Stock | 16,758 | 8.11 | 135.9K | 420,035 | — | ↗ |
| 2024-03-15 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 4,551 | 7.70 | 35.0K | 223,349 | — | ↗ |
| 2024-03-15 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 6,714 | 7.70 | 51.7K | 376,359 | — | ↗ |
| 2024-03-15 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 8,624 | 7.70 | 66.4K | 332,914 | — | ↗ |
| 2024-03-15 | HULL CARL | Director / Officer | F-InKind | D | Class A Common Stock | 17,560 | 7.70 | 135.2K | 267,072 | — | ↗ |
| 2024-03-15 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 5,383 | 7.70 | 41.4K | 258,007 | — | ↗ |
| 2024-03-15 | BUZZEO REBECCA | Officer | F-InKind | D | Class A Common Stock | 4,366 | 7.70 | 33.6K | 365,066 | — | ↗ |
| 2024-02-15 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 2,322 | 5.48 | 12.7K | 227,900 | — | ↗ |
| 2024-02-15 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 2,664 | 5.48 | 14.6K | 341,538 | — | ↗ |
| 2024-02-15 | HULL CARL | Director / Officer | F-InKind | D | Class A Common Stock | 10,729 | 5.48 | 58.8K | 284,632 | — | ↗ |
| 2024-02-15 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 1,941 | 5.48 | 10.6K | 263,390 | — | ↗ |
| 2024-01-16 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 166,852 | 0.00 | — | 230,222 | — | ↗ |
| 2024-01-16 | MARTIN WILLIAM E. III | Officer | A-Award | A | Class A Common Stock | 758,415 | 0.00 | — | 1,040,273 | — | ↗ |
| 2024-01-16 | Leddy Peter Michael | Officer | A-Award | A | Class A Common Stock | 250,277 | 0.00 | — | 383,073 | — | ↗ |
| 2024-01-16 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 250,277 | 0.00 | — | 344,202 | — | ↗ |
| 2024-01-16 | HULL CARL | Director / Officer | A-Award | A | Class A Common Stock | 75,842 | 0.00 | — | 295,361 | — | ↗ |
| 2024-01-16 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 189,604 | 0.00 | — | 265,331 | — | ↗ |
| 2024-01-16 | BUZZEO REBECCA | Officer | A-Award | A | Class A Common Stock | 288,198 | 0.00 | — | 369,432 | — | ↗ |
| 2024-01-16 | BURCH ANDREW | Officer | A-Award | A | Class A Common Stock | 295,782 | 0.00 | — | 436,793 | — | ↗ |
| 2023-11-15 | BUZZEO REBECCA | Officer | F-InKind | D | Class A Common Stock | 4,549 | 5.19 | 23.6K | 81,234 | — | ↗ |
| 2023-10-31 | Leddy Peter Michael | Officer | A-Award | A | Class A Common Stock | 449 | 5.83 | 2.6K | 132,796 | — | ↗ |
| 2023-10-31 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 1,861 | 5.83 | 10.8K | 93,925 | — | ↗ |
| 2023-10-31 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 1,729 | 5.83 | 10.1K | 75,727 | — | ↗ |
| 2023-10-16 | MARTIN WILLIAM E. III | Officer | F-InKind | D | Class A Common Stock | 66,197 | 7.54 | 499.1K | 281,858 | — | ↗ |
| 2023-08-21 | MARTIN WILLIAM E. III | Officer | A-Award | A | Performance Stock Units | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2023-07-20 | DeFord John A | Director | A-Award | A | Class A Common Stock | 31,901 | 0.00 | — | 31,901 | — | ↗ |
| 2023-07-17 | PRAHALAD MURALI | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 44,823 | — | ↗ |
| 2023-07-17 | MIHAS CONSTANTINE S | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 28,271 | — | ↗ |
| 2023-07-17 | MARKER LUKE JOSEPH | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 28,271 | — | ↗ |
| 2023-07-17 | Leddy Peter Michael | Officer | F-InKind | D | Class A Common Stock | 5,578 | 12.52 | 69.8K | 132,347 | — | ↗ |
| 2023-07-17 | LUCIER GREGORY T | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 55,123 | — | ↗ |
| 2023-07-17 | Hopfield Jessica | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 90,123 | — | ↗ |
| 2023-07-17 | GRAY SUSANNAH | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 60,123 | — | ↗ |
| 2023-07-17 | DAVERMAN BENJAMIN JAMES | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 28,271 | — | ↗ |
| 2023-07-17 | CUNNINGHAM SEAN LAURENCE | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 28,271 | — | ↗ |
| 2023-07-17 | Ashkenazi Anat | Director | A-Award | A | Class A Common Stock | 24,000 | 0.00 | — | 40,123 | — | ↗ |
| 2023-04-28 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 1,014 | 11.72 | 11.9K | 63,370 | — | ↗ |
| 2023-04-28 | Leddy Peter Michael | Officer | A-Award | A | Class A Common Stock | 1,920 | 11.72 | 22.5K | 137,925 | — | ↗ |
| 2023-04-28 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 874 | 11.72 | 10.2K | 92,064 | — | ↗ |
| 2023-04-28 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 1,394 | 11.72 | 16.3K | 73,998 | — | ↗ |
| 2023-04-17 | BURCH ANDREW | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 80,000 | 14.14 | 1.13M | 80,000 | — | ↗ |
| 2023-03-31 | BUZZEO REBECCA | Officer | — | D | Class A Common Stock | 0 | 0.00 | — | 85,783 | — | ↗ |
| 2023-03-31 | BURCH ANDREW | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-15 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 38,386 | 0.00 | — | 62,356 | — | ↗ |
| 2023-03-15 | Leddy Peter Michael | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 143,000 | 15.52 | 2.22M | 143,000 | — | ↗ |
| 2023-03-15 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 72,507 | 0.00 | — | 91,190 | — | ↗ |
| 2023-03-15 | HULL CARL | Director / Officer | A-Award | A | Class A Common Stock | 147,638 | 0.00 | — | 219,519 | — | ↗ |
| 2023-03-15 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 55,775 | 0.00 | — | 72,604 | — | ↗ |
| 2023-02-15 | ORESHACK KURT | Officer | F-InKind | D | Class A Common Stock | 2,312 | 15.23 | 35.2K | 23,970 | — | ↗ |
| 2023-02-15 | NEEL BRIAN | Officer | F-InKind | D | Class A Common Stock | 2,312 | 15.23 | 35.2K | 16,473 | — | ↗ |
| 2023-02-15 | Herde Kevin | Officer | F-InKind | D | Class A Common Stock | 2,611 | 15.23 | 39.8K | 18,683 | — | ↗ |
| 2023-02-15 | HULL CARL | Director / Officer | F-InKind | D | Class A Common Stock | 9,719 | 15.23 | 148.0K | 71,881 | — | ↗ |
| 2023-02-15 | Dolan Christine | Officer | F-InKind | D | Class A Common Stock | 1,956 | 15.23 | 29.8K | 16,829 | — | ↗ |
| 2023-01-22 | GTCR INVESTMENT XI LLC | Director | D-Return | D | Common Units | 4,575,170 | 0.00 | — | 119,094,026 | — | ↗ |
| 2022-10-31 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 351 | 14.11 | 5.0K | 26,282 | — | ↗ |
| 2022-10-31 | NEEL BRIAN | Officer | A-Award | A | Class A Common Stock | 329 | 14.11 | 4.6K | 18,785 | — | ↗ |
| 2022-10-31 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 478 | 14.11 | 6.7K | 21,294 | — | ↗ |
| 2022-10-17 | MARTIN WILLIAM E. III | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 403,946 | 0.00 | — | 403,946 | — | ↗ |
| 2022-07-15 | Leddy Peter Michael | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 122,893 | 0.00 | — | 122,893 | — | ↗ |
| 2022-06-27 | Leddy Peter Michael | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-29 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 394 | 22.95 | 9.0K | 25,931 | — | ↗ |
| 2022-04-29 | NEEL BRIAN | Officer | A-Award | A | Class A Common Stock | 572 | 22.95 | 13.1K | 18,456 | — | ↗ |
| 2022-04-29 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 427 | 22.95 | 9.8K | 20,816 | — | ↗ |
| 2022-04-29 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 666 | 22.95 | 15.3K | 18,785 | — | ↗ |
| 2022-01-28 | PRAHALAD MURALI | Director | G-Gift | D | Class A Common Stock | 3,000 | 0.00 | — | 31,123 | — | ↗ |
| 2022-01-25 | ORESHACK KURT | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 31,500 | 26.32 | 829.1K | 31,500 | — | ↗ |
| 2022-01-25 | NEEL BRIAN | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 31,500 | 26.32 | 829.1K | 31,500 | — | ↗ |
| 2022-01-25 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 19,500 | 0.00 | — | 20,389 | — | ↗ |
| 2022-01-25 | HULL CARL | Director / Officer | A-Award | A | Class A Common Stock | 81,600 | 0.00 | — | 81,600 | — | ↗ |
| 2022-01-25 | Dolan Christine | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 31,500 | 26.32 | 829.1K | 31,500 | — | ↗ |
| 2021-12-31 | GTCR INVESTMENT XI LLC | Director / 10% Owner | D-Return | D | Common Units | 2,570,415 | 0.00 | — | 123,669,196 | — | ↗ |
| 2021-11-19 | PRAHALAD MURALI | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 34,123 | — | ↗ |
| 2021-11-19 | MIHAS CONSTANTINE S | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 4,271 | — | ↗ |
| 2021-11-19 | MARKER LUKE JOSEPH | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 4,271 | — | ↗ |
| 2021-11-19 | LUCIER GREGORY T | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 31,123 | — | ↗ |
| 2021-11-19 | Hopfield Jessica | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 66,123 | — | ↗ |
| 2021-11-19 | Hance Robert B | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 26,123 | — | ↗ |
| 2021-11-19 | GRAY SUSANNAH | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 36,123 | — | ↗ |
| 2021-11-19 | DAVERMAN BENJAMIN JAMES | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 4,271 | — | ↗ |
| 2021-11-19 | CUNNINGHAM SEAN LAURENCE | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 4,271 | — | ↗ |
| 2021-11-19 | Ashkenazi Anat | Director | A-Award | A | Class A Common Stock | 4,271 | 0.00 | — | 16,123 | — | ↗ |
| 2021-10-31 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 542 | 22.95 | 12.4K | 8,537 | — | ↗ |
| 2021-10-31 | NEEL BRIAN | Officer | A-Award | A | Class A Common Stock | 598 | 22.95 | 13.7K | 884 | — | ↗ |
| 2021-10-31 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 392 | 22.95 | 9.0K | 889 | — | ↗ |
| 2021-10-31 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 203 | 22.95 | 4.7K | 1,119 | — | ↗ |
| 2021-09-09 | GTCR INVESTMENT XI LLC | Director / 10% Owner | D-Return | D | Common Units | 17,068,559 | 0.00 | — | 126,239,611 | — | ↗ |
| 2021-04-30 | ORESHACK KURT | Officer | A-Award | A | Class A Common Stock | 495 | 22.95 | 11.4K | 7,995 | — | ↗ |
| 2021-04-30 | NEEL BRIAN | Officer | A-Award | A | Class A Common Stock | 286 | 22.95 | 6.6K | 286 | — | ↗ |
| 2021-04-30 | Herde Kevin | Officer | A-Award | A | Class A Common Stock | 497 | 22.95 | 11.4K | 497 | — | ↗ |
| 2021-04-30 | Dolan Christine | Officer | A-Award | A | Class A Common Stock | 916 | 22.95 | 21.0K | 916 | — | ↗ |
| 2021-04-08 | GTCR INVESTMENT XI LLC | Director / 10% Owner | J-Other | D | Class B Common Stock | 2,304,256 | 0.01 | 23.0K | 143,308,170 | — | ↗ |
| 2021-04-07 | GTCR INVESTMENT XI LLC | Director / 10% Owner | J-Other | D | Class B Common Stock | 15,361,703 | 0.01 | 153.6K | 145,612,426 | — | ↗ |
| 2020-11-25 | HULL CARL | Director / Officer | P-Purchase | A | Class A Common Stock | 35,000 | 26.94 | 942.9K | 35,000 | — | ↗ |
| 2020-11-24 | SELLERS LISA | Officer | P-Purchase | A | Class A Common Stock | 18,888 | 27.00 | 510.0K | 18,888 | — | ↗ |
| 2020-11-24 | PRAHALAD MURALI | Director | P-Purchase | A | Class A Common Stock | 18,000 | 27.00 | 486.0K | 29,852 | — | ↗ |
| 2020-11-24 | ORESHACK KURT | Officer | P-Purchase | A | Class A Common Stock | 7,500 | 27.00 | 202.5K | 7,500 | — | ↗ |
| 2020-11-24 | LUCIER GREGORY T | Director | P-Purchase | A | Class A Common Stock | 15,000 | 27.00 | 405.0K | 26,852 | — | ↗ |
| 2020-11-24 | Hopfield Jessica | Director | P-Purchase | A | Class A Common Stock | 50,000 | 27.00 | 1.35M | 61,852 | — | ↗ |
| 2020-11-24 | Hance Robert B | Director | P-Purchase | A | Class A Common Stock | 10,000 | 27.00 | 270.0K | 21,852 | — | ↗ |
| 2020-11-24 | GTCR INVESTMENT XI LLC | Director / 10% Owner | J-Other | D | Class B Common Stock | 7,680,852 | 0.01 | 76.8K | 160,974,129 | — | ↗ |
| 2020-11-24 | GRAY SUSANNAH | Director | P-Purchase | A | Class A Common Stock | 20,000 | 27.00 | 540.0K | 31,852 | — | ↗ |
| 2020-11-19 | Tardif Eric | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | SELLERS LISA | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | PRAHALAD MURALI | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | ORESHACK KURT | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | NEEL BRIAN | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 60,000 | 27.00 | 1.62M | 60,000 | — | ↗ |
| 2020-11-19 | MIHAS CONSTANTINE S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | MARKER LUKE JOSEPH | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | LUCIER GREGORY T | Director | A-Award | A | Class A Common Stock | 11,852 | 0.00 | — | 11,852 | — | ↗ |
| 2020-11-19 | Hopfield Jessica | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | Herde Kevin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | Hance Robert B | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | HULL CARL | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | GTCR INVESTMENT XI LLC | Director / 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 28,965,664 | — | ↗ |
| 2020-11-19 | GRAY SUSANNAH | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | Dolan Christine | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | DAVERMAN BENJAMIN JAMES | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | CUNNINGHAM SEAN LAURENCE | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-19 | Ashkenazi Anat | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-364.9K
Shares Outstanding
144.32M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Bernd Brust Chief Executive Officer | 388.9K | — | 7.66M | 1.46M | 425.3K | 195.5K | 10.13M | 90.03% | ↗ |
| 2 | 2025 | William E. Martin III Former Chief Executive Officer | 345.0K | — | 2.60M | — | — | 896.7K | 3.85M | 67.71% | ↗ |
| 3 | 2025 | Raj Asarpota Chief Financial Officer | 253.4K | 200.0K | 2.17M | 483.3K | 195.1K | 202.5K | 3.51M | 75.73% | ↗ |
| 4 | 2025 | Peter Leddy, PhD Chief Administrative Officer | 372.2K | — | 1.04M | — | 115.8K | 320.3K | 1.85M | 56.30% | ↗ |
| 5 | 2025 | Kevin Herde Former Chief Financial Officer | 247.8K | — | 1.04M | — | — | 441.5K | 1.73M | 60.17% | ↗ |
| 6 | 2025 | Kurt Oreshack Secretary and General Counsel | 455.4K | — | 781.1K | — | 225.3K | 9.2K | 1.47M | 53.10% | ↗ |
| 7 | 2025 | Christine Dolan Executive Vice President and General Manager, Cygnus | 451.0K | — | 650.9K | — | 343.2K | 9.2K | 1.45M | 44.76% | ↗ |
| 8 | 2024 | William E. Martin III Former Chief Executive Officer | 775.4K | — | 4.88M | — | 492.4K | 236.0K | 6.38M | 76.43% | ↗ |
| 9 | 2024 | William E. Martin, III Chief Executive Officer | 775.4K | — | 4.88M | — | 492.4K | 236.0K | 6.38M | 76.43% | ↗ |
| 10 | 2024 | Andrew Burch Former President, Nucleic Acid Production | 472.6K | 40.0K | 1.90M | — | 134.6K | 9.2K | 2.56M | 74.34% | ↗ |
| 11 | 2024 | Rebecca Buzzeo Chief Commercial Officer | 465.2K | 46.8K | 1.85M | — | 94.5K | — | 2.46M | 75.34% | ↗ |
| 12 | 2024 | Peter Leddy, PhD Chief Administrative Officer | 483.1K | 68.1K | 1.61M | — | 137.6K | 65.6K | 2.36M | 68.08% | ↗ |
| 13 | 2024 | Kevin Herde Former Chief Financial Officer | 489.3K | 69.0K | 1.61M | — | 139.4K | 32.3K | 2.34M | 68.79% | ↗ |
| 14 | 2024 | Kevin Herde Chief Financial Officer | 489.3K | 69.0K | 1.61M | — | 139.4K | 32.3K | 2.34M | 68.79% | ↗ |
| 15 | 2023 | Carl Hull Executive Chairman and Former Interim Chief Executive Officer | 617.7K | — | 2.29M | 2.31M | — | — | 5.22M | 88.16% | ↗ |
| 16 | 2023 | Andrew Burch President, Nucleic Acid Production | 371.5K | 44.5K | 1.99M | 573.8K | — | 9.2K | 2.99M | 85.79% | ↗ |
| 17 | 2023 | Andrew Burch Former President, Nucleic Acid Production | 371.5K | 44.5K | 1.99M | 573.8K | — | 9.2K | 2.99M | 85.79% | ↗ |
| 18 | 2023 | Peter Leddy, PhD Chief Administrative Officer | 467.1K | 75.7K | 1.13M | 1.12M | — | 40.5K | 2.83M | 79.37% | ↗ |
| 19 | 2023 | Kevin Herde Former Chief Financial Officer | 472.8K | 66.7K | 1.13M | 1.12M | — | 9.2K | 2.79M | 80.36% | ↗ |
| 20 | 2023 | Kevin Herde Chief Financial Officer | 472.8K | 66.7K | 1.13M | 1.12M | — | 9.2K | 2.79M | 80.36% | ↗ |
| 21 | 2023 | William E. Martin III Former Chief Executive Officer | 750.0K | — | 1.31M | — | — | 237.9K | 2.30M | 57.08% | ↗ |
| 22 | 2023 | William E. Martin, III Chief Executive Officer | 750.0K | — | 1.31M | — | — | 237.9K | 2.30M | 57.08% | ↗ |
| 23 | 2023 | Christine Dolan General Manager, Cygnus Technologies | 455.4K | 70.3K | 865.6K | 860.8K | — | 10.9K | 2.26M | 76.29% | ↗ |
| 24 | 2022 | William E. Martin, III Chief Executive Officer | 660.4K | 470.0K | 8.03M | 4.43M | 937.5K | 1.7K | 14.52M | 85.75% | ↗ |
| 25 | 2022 | William E. Martin, III Former Chief Executive Officer | 660.4K | 470.0K | 8.03M | 4.43M | 937.5K | 1.7K | 14.52M | 85.75% | ↗ |
| 26 | 2022 | Carl Hull Chief Executive Officer and Executive Chairman of the Board | 721.4K | — | 2.15M | 1.88M | 732.3K | — | 5.48M | 73.48% | ↗ |
| 27 | 2022 | Carl Hull Executive Chairman and Former Interim Chief Executive Officer | 721.4K | — | 2.15M | 1.88M | 732.3K | — | 5.48M | 73.48% | ↗ |
| 28 | 2022 | Peter Leddy, Ph.D. Chief Administrative Officer | 333.7K | 100.0K | 1.58M | 1.58M | 318.2K | 5.2K | 3.92M | 80.71% | ↗ |
| 29 | 2022 | Peter Leddy, PhD Chief Administrative Officer | 333.7K | 100.0K | 1.58M | 1.58M | 318.2K | 5.2K | 3.92M | 80.71% | ↗ |
| 30 | 2022 | Kevin Herde Chief Financial Officer | 448.4K | — | 513.2K | 450.0K | 320.7K | 9.2K | 1.74M | 55.31% | ↗ |
| 31 | 2022 | Christine Dolan Chief Operating Officer, Biologics Safety Testing | 436.6K | — | 447.4K | 391.5K | 310.3K | 9.2K | 1.59M | 52.60% | ↗ |
| 32 | 2022 | Christine Dolan General Manager, Cygnus Technologies | 436.6K | — | 447.4K | 391.5K | 310.3K | 9.2K | 1.59M | 52.60% | ↗ |
| 33 | 2022 | Brian Neel Chief Operating Officer, Nucleic Acid Production | 432.2K | — | 447.4K | 391.5K | 309.7K | 8.7K | 1.58M | 53.07% | ↗ |
| 34 | 2021 | Lisa Sellers Former Chief Operating Officer, Protein Detection | 291.9K | 250.0K | — | 2.44M | — | — | 2.98M | 81.84% | ↗ |
| 35 | 2021 | Carl Hull Executive Chairman and Former Interim Chief Executive Officer | 580.8K | — | — | — | 1.20M | — | 1.78M | 0.00% | ↗ |
| 36 | 2021 | Carl Hull Chief Executive Officer | 580.8K | — | — | — | 1.20M | — | 1.78M | 0.00% | ↗ |
| 37 | 2021 | Carl Hull Chief Executive Officer and Executive Chairman of the Board | 580.8K | — | — | 874.2K | 1.20M | — | 1.78M | 49.09% | ↗ |
| 38 | 2021 | Christine Dolan Chief Operating Officer, Biologics Safety Testing | 411.9K | — | — | — | 424.0K | 8.8K | 844.7K | 0.00% | ↗ |
| 39 | 2021 | Christine Dolan General Manager, Cygnus Technologies | 411.9K | — | — | — | 424.0K | 8.8K | 844.7K | 0.00% | ↗ |
| 40 | 2021 | Kevin Herde Chief Financial Officer | 412.8K | — | — | — | 420.0K | 8.8K | 841.6K | 0.00% | ↗ |
| 41 | 2021 | Brian Neel Chief Operating Officer, Nucleic Acid Production | 388.7K | — | — | 874.2K | 400.0K | 8.6K | 797.4K | 109.63% | ↗ |
| 42 | 2021 | Kurt Oreshack General Counsel and Secretary | 383.9K | — | — | — | 308.8K | 8.7K | 701.4K | 0.00% | ↗ |
| 43 | 2020 | Carl Hull Chief Executive Officer and Executive Chairman of the Board | 500.0K | — | — | — | 750.0K | — | 2.12M | 0.00% | ↗ |
| 44 | 2020 | Carl Hull Chief Executive Officer | 500.0K | — | — | 874.2K | 750.0K | — | 2.12M | 41.15% | ↗ |
| 45 | 2020 | Carl Hull, Chief Executive Officer | 500.0K | — | — | 874.2K | 750.0K | — | 2.12M | 41.15% | ↗ |
| 46 | 2020 | Eric Tardif, President and Executive Vice-President, Corporate Development | 404.9K | — | — | 874.2K | 608.8K | 8.6K | 1.90M | 46.10% | ↗ |
| 47 | 2020 | Brian Neel Chief Operating Officer, Nucleic Acid Production | 328.6K | — | — | — | 649.9K | — | 1.86M | 0.00% | ↗ |
| 48 | 2020 | Brian Neel, Chief Operating Officer, Nucleic Acid Production | 328.6K | — | — | 874.2K | 649.9K | 8.6K | 1.86M | 46.97% | ↗ |
| 49 | 2019 | Carl Hull Chief Executive Officer | 485.4K | — | — | 1.74M | 600.0K | — | 2.83M | 61.62% | ↗ |
| 50 | 2019 | Carl Hull, Chief Executive Officer | 485.4K | — | — | 1.74M | 600.0K | — | 2.83M | 61.62% | ↗ |
| 51 | 2019 | Brian Neel, Chief Operating Officer, Nucleic Acid Production | 314.7K | — | — | 428.0K | 142.4K | 8.4K | 893.5K | 47.90% | ↗ |
| 52 | 2019 | Brian Neel Chief Operating Officer, Nucleic Acid Production | 314.7K | — | — | 428.0K | 142.4K | 8.4K | 893.5K | 47.90% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bernd Brust | Chief Executive Officer & Director | 1M | male |
| Rajesh J. Asarpota | Executive Vice President & Chief Financial Officer | 851.0K | male |
| Christine Dolan | Executive Vice President & GM of Cygnus Technologies | 803.3K | female |
| Kurt Oreshack | Executive Vice President, General Counsel & Secretary | 689.9K | male |
| Robert Andrew Eckert | Chairman of the Board | 175.0K | male |
| Debra Hart | Senior Director of Investor Relations | — | female |
| Judith A. Solecki | Senior VP & Chief Human Resources Officer | — | female |
| Kate E. Broderick | Executive Vice President | — | — |
| Christopher Benoit | Executive Vice President & Advisor | — | male |
| Chanfeng Zhao | Senior Vice President & Chief Scientific Officer | — | female |
| Chad Decker | Senior Vice President of Sales at TriLink & Alphazyme | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2023-04-10 | 2023-05-19 | Daniel Goldman | NY10 | — | Sale | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRVI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
